Compound class:
Synthetic organic
Comment: Apstatin is a tri-peptide-like inhibitor of membrane bound aminopeptidase P (mAPP; XPNPEP2) [1], which inhibits mAPP-induced degradation of bradykinin [2].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Maggiora LL, Orawski AT, Simmons WH. (1999)
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme. J Med Chem, 42 (13): 2394-402. [PMID:10395480] |
2. Prechel MM, Orawski AT, Maggiora LL, Simmons WH. (1995)
Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung. J Pharmacol Exp Ther, 275 (3): 1136-42. [PMID:8531074] |